VAERS Explorer
Back to explore

Report #2878398

Received Dec 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH1——

Symptoms (1)

Drug hypersensitivity

Symptom narrative

she has allergies but she is unsure the cause. it may be from covid vaccine; This is a spontaneous report received from an Other HCP and a Consumer or other non HCP from License Party. An adult female patient (unknown if pregnant) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; dupilumab (DUPIXENT). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG HYPERSENSITIVITY (non-serious), outcome "unknown", described as "she has allergies but she is unsure the cause. it may be from covid vaccine". The action taken for dupilumab was unknown. Clinical course: The patient developed a non-serious event "stated she gets itching all over when she does not take her Dupient" and stated that she has allergies but she is unsure the cause, it may be from the covid vaccine. Batch/lot number is not provided, and it cannot be obtained.

Other medications

DUPIXENT